The Technical Analyst
Select Language :
Edgewise Therapeutics, [EWTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Edgewise Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Edgewise Therapeutics, is listed at the  Exchange

1.56% $18.24

America/New_York / 28 mar 2024 @ 16:00


Edgewise Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 698.34 mill
EPS: -1.570
P/E: -11.62
Earnings Date: May 08, 2024
SharesOutstanding: 93.11 mill
Avg Daily Volume: 1.045 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debtn/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -11.62 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.98x
Company: PE -11.62 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.266
(-93.06%) $-16.97
Date: 2024-03-29
Expected Trading Range (DAY)

$ 17.22 - 19.22

( +/- 5.50%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-07 Moore John R Sell 17 993 Stock Option (Right to Buy)
2024-02-08 Moore John R Sell 3 813 Stock Option (Right to Buy)
2024-02-09 Moore John R Sell 8 029 Stock Option (Right to Buy)
2024-02-07 Moore John R Buy 17 993 Common Stock
2024-02-09 Moore John R Buy 8 029 Common Stock
INSIDER POWER
74.97
Last 97 transactions
Buy: 6 997 164 | Sell: 659 479

Forecast: 16:00 - $18.23

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $18.23
Forecast 2: 16:00 - $18.23
Forecast 3: 16:00 - $18.23
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $18.24 (1.56% )
Volume 0.462 mill
Avg. Vol. 1.045 mill
% of Avg. Vol 44.20 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Edgewise Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Edgewise Therapeutics, Inc.

RSI

Intraday RSI14 chart for Edgewise Therapeutics, Inc.

Last 10 Buy & Sell Signals For EWTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$19.98N/AActive
Profile picture for
            Edgewise Therapeutics, Inc.

EWTX

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Last 10 Buy Signals

Date Signal @
OMUSDMar 29 - 05:190.710
KUBUSDMar 29 - 05:132.70
EOSUSDMar 29 - 05:15$1.083
HATUSDMar 29 - 05:023 532.25
FETUSDMar 29 - 04:58$3.24
SOCKSUSDMar 29 - 04:5335 606
OSHIUSDMar 29 - 04:4981.91
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.